Search results
A Quick Glance At Apellis Pharmaceuticals Inc (NASDAQ: APLS) Stock: It Is up 52.22% From Its 52-Week...
Marketing Sentinel· 7 hours agoWhile earnings are projected to return 78.65% in 2024, the next five years will return 33.30% per annum. APLS Dividends Apellis Pharmaceuticals Inc is due ...
Ani Pharmaceuticals CFO sells shares worth over $317k By Investing.com
Investing.com· 3 hours agoANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has reported a significant transaction involving its Senior...
GSK plc (NYSE:GSK) Stock Position Decreased by Peapack Gladstone Financial Corp
ETF DAILY NEWS· 6 hours agoThe institutional investor owned 23,173 shares of the pharmaceutical company’s stock after selling 1,441 shares during the quarter. Peapack Gladstone Financial Corp’s holdings ...
Earnings call: Novartis outlines strong forecast for Scemblix in CML treatment By Investing.com
Investing.com· 1 day agoNovartis has projected robust sales for its new chronic myeloid leukemia (CML) treatment, Scemblix,...
Fennec Pharmaceuticals Inc (NASDAQ:FENC) CEO Rosty Raykov Sells 2,431 Shares of Stock
ETF DAILY NEWS· 2 days agoFennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) CEO Rosty Raykov sold 2,431 shares of the company’s stock in a transaction on Monday, June 3rd. Following the completion ...
ICL Group Ltd's Dividend Analysis
GuruFocus.com via Yahoo Finance· 3 hours agoSince 1999, ICL Group Ltd has maintained a steady record of dividend payments, distributed quarterly to its shareholders. Below, you can view a chart...
CSPC Pharma Weighs Up Diet Drug For Bigger Bottom Line - CSPC Pharma Gr (OTC:CSPCY), Novo Nordisk...
Benzinga· 20 hours agoIn the pharmaceutical business, research to develop candidate drugs is never guaranteed to pay off,...
Crinetics Pharmaceuticals (NASDAQ:CRNX) Given “Buy” Rating at HC Wainwright
ETF DAILY NEWS· 2 days agoCrinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a note issued to investors on Tuesday ...
Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com
ETF DAILY NEWS· 7 days agoAnalysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report released on Friday. The brokerage set a “sell” rating ...
Astrazeneca (AZN) Beats Stock Market Upswing: What Investors Need to Know
Zacks· 3 days agoFree Report) closed the most recent trading day at $78.99, moving +1.24% from the previous trading session. This move outpaced the S&P 500's daily gain of 0.11%. Coming into today, shares of ...
